Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice-Reference-Cited by-同舟云学术

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

Published:2007-06 Issue: Volume:18 Page:vi124-vi127
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gebbia V.,Maiello E.,Giuliani F.,Borsellino N.,Caruso M.,Di Maggio G.,Ferraù F.,Bordonaro R.,Verderame F.,Tralongo P.,Di Cristina L.,Agueli R.,Russo P.,Colucci G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/18/suppl_6/vi124/6673355/mdm240.pdf

Reference15 articles.

1. Cytotoxic chemotherapy for pancreatic cancer: Advances to date and future directions;Xiong;Drugs,2006

2. Chemotherapy for advanced pancreatic cancer;Chua;Best Pract Res Clin Gastroenterol,2006

3. Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologico dell’Italia Meridionale;Colucci;Cancer,2002

4. Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and non-cross-resistant treatment for chemotherapy refractory metastatic pancreatic cancer;Kozuch;Oncologist,2001

5. Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma;Bonetti;Ann Oncol,2001

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head‐to‐head comparison of treatment sequences in advanced pancreatic cancer—Real‐world data from the prospective German TPK clinical cohort study;International Journal of Cancer;2024-07-02

2. Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis;BMC Gastroenterology;2023-06-19

3. Pancreatic adenocarcinoma: Beyond first line, where are we?;World Journal of Gastroenterology;2021-05-07

4. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens;BMC Cancer;2020-07-08

5. Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy;JCI Insight;2020-04-23